🇺🇸 FDA
Patent

US 9205131

Use of IL-17D for the treatment and prevention of cancers

granted A61KA61K38/20A61P

Quick answer

US patent 9205131 (Use of IL-17D for the treatment and prevention of cancers) held by The Regents of the University of California expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/20, A61P, A61P35/00